TD Waterhouse Canada Inc. Has $5.29 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

TD Waterhouse Canada Inc. reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 25.4% in the fourth quarter, holding 6,856 shares valued at $5.29 million. Other institutional investors showed mixed activity, with some increasing and others acquiring new stakes. Insiders recently sold a total of 3,774 shares, while analysts have a “Moderate Buy” consensus rating for REGN with an average price target of $811.96.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin